RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
EVENT
Committee for Orphan Medicinal Products (COMP): 1-3 December 2026
Published: 12/1/2026Detected: 11/19/2026

Summary preview

Agenda listing for the COMP meeting on 1–3 December 2026, focused on orphan medicinal product activities within the EU rare disease framework.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
rare_diseases
clinical
safety
labeling
quality
manufacturing
#EMA
#COMP
#orphan medicinal products
#rare diseases
#orphan designation

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Committee for Advanced Therapies (CAT): 2-4 December 202612/2/2026
  • Committee for Medicinal Products for Veterinary Use (CVMP): 1-3 December 202612/1/2026
  • Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection12/1/2026
  • Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/30/2026
  • ACT EU workshop on multiplicity in confirmatory clinical trials: From two-arm to platform trials11/27/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.